| http://dbpedia.org/ontology/abstract
|
لكساتوموماب جسم مضاد وحيد النسيلة بشري تجري عليه التجارب السريرية لاستخدامه في علاج السرطان.
, Il lexatumumab o ETR2-ST01, è un anticorpo monoclonale di tipo umano, che viene studiato per il trattamento di forme di tumore. Esso è stato sviluppato dalla , Inc.. Il farmaco agisce sull'antigene: -R2.
, Lexatumumab (also known as ETR2-ST01) is a … Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2), intended for the treatment of cancer. HGS-ETR2 antibodies were generated by Human Genome Sciences through a collaboration with Cambridge Antibody Technology. Development was discontinued in 2015.ogy. Development was discontinued in 2015.
|
| http://dbpedia.org/ontology/casNumber
|
845816-02-6
|
| http://dbpedia.org/ontology/fdaUniiCode
|
967Q0SJD77
|
| http://dbpedia.org/ontology/kegg
|
D06611
|
| http://dbpedia.org/ontology/wikiPageID
|
9700526
|
| http://dbpedia.org/ontology/wikiPageLength
|
2767
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1058530797
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Monoclonal_antibodies_for_tumors +
, http://dbpedia.org/resource/Cancer +
, http://dbpedia.org/resource/Human_Genome_Sciences +
, http://dbpedia.org/resource/Category:Experimental_cancer_drugs +
, http://dbpedia.org/resource/TRAIL-R2 +
, http://dbpedia.org/resource/Cambridge_Antibody_Technology +
, http://dbpedia.org/resource/Monoclonal_antibody +
, http://dbpedia.org/resource/Human +
|
| http://dbpedia.org/property/atcPrefix
|
none
|
| http://dbpedia.org/property/c
|
6346
|
| http://dbpedia.org/property/casNumber
|
845816
|
| http://dbpedia.org/property/chemspiderid
|
none
|
| http://dbpedia.org/property/h
|
9832
|
| http://dbpedia.org/property/kegg
|
D06611
|
| http://dbpedia.org/property/mabType
|
mab
|
| http://dbpedia.org/property/n
|
1720
|
| http://dbpedia.org/property/o
|
2002
|
| http://dbpedia.org/property/s
|
42
|
| http://dbpedia.org/property/source
|
u
|
| http://dbpedia.org/property/target
|
TRAIL-R2
|
| http://dbpedia.org/property/type
|
mab
|
| http://dbpedia.org/property/unii
|
967
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
458270193
|
| http://dbpedia.org/property/watchedfields
|
changed
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Keggcite +
, http://dbpedia.org/resource/Template:Antineoplastic-drug-stub +
, http://dbpedia.org/resource/Template:Monoclonal-antibody-stub +
, http://dbpedia.org/resource/Template:Monoclonals_for_tumors +
, http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Drugbox +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Monoclonal_antibodies_for_tumors +
, http://dbpedia.org/resource/Category:Experimental_cancer_drugs +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Antibody +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Lexatumumab?oldid=1058530797&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Lexatumumab +
|
| owl:sameAs |
http://dbpedia.org/resource/Lexatumumab +
, http://it.dbpedia.org/resource/Lexatumumab +
, https://global.dbpedia.org/id/BWdQ +
, http://ar.dbpedia.org/resource/%D9%84%D9%83%D8%B3%D8%A7%D8%AA%D9%88%D9%85%D9%88%D9%85%D8%A7%D8%A8 +
, http://www.wikidata.org/entity/Q1112374 +
, http://rdf.freebase.com/ns/m.02ppkg1 +
, http://yago-knowledge.org/resource/Lexatumumab +
|
| rdf:type |
http://dbpedia.org/ontology/MonoclonalAntibody +
, http://dbpedia.org/class/yago/WikicatMonoclonalAntibodies +
, http://dbpedia.org/class/yago/MonoclonalAntibody115029781 +
, http://dbpedia.org/class/yago/Antibody115027189 +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/class/yago/WikicatMonoclonalAntibodiesForTumors +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/Protein114728724 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
, http://dbpedia.org/class/yago/Macromolecule114944888 +
, http://dbpedia.org/class/yago/Molecule114682133 +
, http://dbpedia.org/class/yago/Unit109465459 +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://dbpedia.org/class/yago/Thing100002452 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/Drug +
, http://umbel.org/umbel/rc/DrugProduct +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
|
| rdfs:comment |
Lexatumumab (also known as ETR2-ST01) is a … Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2), intended for the treatment of cancer. HGS-ETR2 antibodies were generated by Human Genome Sciences through a collaboration with Cambridge Antibody Technology. Development was discontinued in 2015.ogy. Development was discontinued in 2015.
, لكساتوموماب جسم مضاد وحيد النسيلة بشري تجري عليه التجارب السريرية لاستخدامه في علاج السرطان.
, Il lexatumumab o ETR2-ST01, è un anticorpo monoclonale di tipo umano, che viene studiato per il trattamento di forme di tumore. Esso è stato sviluppato dalla , Inc.. Il farmaco agisce sull'antigene: -R2.
|
| rdfs:label |
Lexatumumab
, لكساتوموماب
|
